{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T09:46:37Z","timestamp":1767260797678},"reference-count":30,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Forum Allergy Rhinol"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>A major component of sputum in cystic fibrosis (CF) patients is polymerized DNA, a byproduct of degraded neutrophils. Dornase alfa (dornase) selectively cleaves extracellular DNA and reduces the viscosity of sputum. It improves mucociliary clearance and pulmonary function. The benefit of dornase on CF\u2010associated sinusitis is less clear. Therefore, the objective of this study was to systematically review the use of dornase on chronic rhinosinusitis (CRS) in CF patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The Preferred Reporting Items for Systematic Reviews and Meta\u2010Analyses statement was followed for this systematic review. Ovid Medline, EMBASE, PubMed, and the Cochrane Library were searched. The search terms \u201cdornase alfa,\u201d \u201cdeoxyribonucleases,\u201d \u201crhinosinusitis,\u201d and \u201ccystic fibrosis\u201d were used to find articles published between 1990 and 2016. The articles were reviewed for study design, level of evidence, and clinical outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Sixty\u2010two articles were identified; 6 met the inclusion criteria (104 patients). Improvement measured by sinonasal symptoms, endoscopic and radiographic findings, and pulmonary function was variably reported between the studies. Sinonasal symptoms were shown to improve in all studies with use of intranasal topical dornase. Three placebo\u2010controlled studies showed that topical dornase significantly improved sinonasal symptoms more than saline alone. The impact on pulmonary function and radiographic and endoscopy findings was variable.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Topical intranasal dornase appears to improve sinonasal symptoms in CF patients to a greater degree than saline alone. The impact on other outcomes is less clear. Larger studies are needed to fully elucidate the true efficacy of dornase alfa in the treatment of CRS in CF patients.<\/jats:p><\/jats:sec>","DOI":"10.1002\/alr.22082","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T15:25:40Z","timestamp":1515684340000},"page":"729-736","source":"Crossref","is-referenced-by-count":22,"title":["Treatment of chronic rhinosinusitis with dornase alfa in patients with cystic fibrosis: a systematic review"],"prefix":"10.1002","volume":"8","author":[{"given":"Gopi B.","family":"Shah","sequence":"first","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery University of Texas\u2010Southwestern Medical Center and Children's Health Dallas  Dallas TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linde","family":"De Keyzer","sequence":"additional","affiliation":[{"name":"Department of Pulmonology University of Texas\u2010Southwestern Medical Center and Children's Health  Dallas TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy A.","family":"Russell","sequence":"additional","affiliation":[{"name":"Health Sciences Digital Library and Learning Center University of Texas\u2010Southwestern Medical Center  Dallas TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashleigh","family":"Halderman","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery University of Texas\u2010Southwestern Medical Center and Children's Health Dallas  Dallas TX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(13)00150-1"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02914539"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.2010.00957.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2008.04.003"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-196503000-00006"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00179910"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2007.02.009"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e328358d51f"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.06.006"},{"key":"e_1_2_6_11_1","first-page":"1","article-title":"Cochrane methods","volume":"1","author":"Chandler JCM","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2014.02.005"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2010.09.001"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(10)60089-6"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","unstructured":"HaynesF DewarJ.Control of sinonasal symptoms improves quality of life. Journal of Cystic Fibrosis Conference: 36th European Cystic Fibrosis Conference Lisbon Portugal Conference Start.12(ppS104).","DOI":"10.1016\/S1569-1993(13)60361-6"},{"key":"e_1_2_6_17_1","first-page":"354","article-title":"The effect of intranasal dornase alfa on chronic sinusitis in patients with cystic fibrosis: a pilot study","volume":"47","author":"Lahiri T","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.131.12.1097"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(11)60395-0"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.126.5.581"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2016.05.003"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin11.271"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1806-37132015000100009"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(09)60005-9"},{"key":"e_1_2_6_25_1","first-page":"298","article-title":"Sinonasal inhalation of mucolytic and antibiotic agents in CF.","volume":"46","author":"Mainz JG","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2013.787427"},{"key":"e_1_2_6_27_1","first-page":"4","article-title":"Dornase alfa for cystic fibrosis","volume":"4","author":"Yang C","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_28_1","first-page":"37","article-title":"Health care utilization & costs for cystic fibrosis patients with pulmonary infections","author":"O'Sullivan AK","year":"2011","journal-title":"Managed Care"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/106002809502900501"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.24503"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21190"}],"container-title":["International Forum of Allergy &amp; Rhinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Falr.22082","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/alr.22082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T15:30:16Z","timestamp":1695483016000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/alr.22082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1002\/alr.22082"],"URL":"https:\/\/doi.org\/10.1002\/alr.22082","archive":["Portico"],"relation":{},"ISSN":["2042-6976","2042-6984"],"issn-type":[{"value":"2042-6976","type":"print"},{"value":"2042-6984","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,11]]}}}